| ARCHETYPE ID | openEHR-EHR-OBSERVATION.charlson_comorbidity_index.v0 |
|---|---|
| Concept | Charlson Comorbidity Index (CCI) |
| Description | An assessment tool used to predict the risk of death from comorbid disease. |
| Use | Use to record the result for each component parameter of the Charlson Comorbidity Index (CCI) and its total sum, and to calculate the 10 year estimated survival. This data is from the original Charlson study in 1987. |
| Purpose | To record the result for each component parameter of the Charlson Comorbidity Index (CCI) and its total sum, and to calculate the 10 year estimated survival. |
| References | Derived from: <Add reference to original resource here> Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8. PubMed PMID: 3558716. |
| Copyright | © openEHR Foundation |
| Authors | Author name: Liv Laugen Organisation: Oslo universitetssykehus Email: liv.laugen@ous-hf.no |
| Other Details Language | Author name: Liv Laugen Organisation: Oslo universitetssykehus Email: liv.laugen@ous-hf.no |
| Other Details (Language Independent) |
|
| Keywords | CCI, comorbidity, concurrent conditions, estimated survival, mortality, prognosis, assessment, risk |
| Lifecycle | in_development |
| UID | d091f097-a2a9-4ca6-b2c5-211947c596ec |
| Language used | en |
| Citeable Identifier | 1013.1.2268 |
| Revision Number | 0.0.1-alpha |
| events | |
| Any event | Any event: Default, unspecified point in time or interval event which may be explicitly defined in a template or at run-time. |
| protocol | |
| Extension SLOT | Extension SLOT: Additional information required to extend the model with local content or to align with other reference models or formalisms. For example: local information requirements; or additional metadata to align with FHIR. Include: All not explicitly excluded archetypes |
| data | |
| Age | Age: Age group of the patient. 0: <50 years 1: 50–59 years 2: 60-69 years 3: 70–79 years 4: ≥80 years |
| Myocardial infarction | Myocardial infarction: History of definite or probable Myocardial infarction (EKG changes and/or enzyme changes). 0: No 1: Yes [History of definite or probable Myocardial infarction (EKG changes and/or enzyme changes).] |
| Congestive heart failure | Congestive heart failure: Exertional or paroxysmal nocturnal dyspnea and has responded to symptomatically (or on physical examination) to digitalis, diuretics, or afterload reducing agents. 0: No 1: Yes [Exertional or paroxysmal nocturnal dyspnea and has responded to symptomatically (or on physical examination) to digitalis, diuretics, or afterload reducing agents.] |
| Peripheral vascular disease | Peripheral vascular disease: Intermittent claudication or past bypass for chronic arterial insufficiency, history of gangrene or acute arterial insufficiency, or untreated thoracic or abdominal aneurysm (≥6 cm). 0: No 1: Yes [Intermittent claudication or past bypass for chronic arterial insufficiency, history of gangrene or acute arterial insufficiency, or untreated thoracic or abdominal aneurysm (≥6 cm).] |
| Cerebrovascular disease | Cerebrovascular disease: History of a cerebrovascular accident (CVA) with minor or no residua and transient ischemic attacks (TIA). 0: No 1: Yes [History of a cerebrovascular accident (CVA) with minor or no residua and transient ischemic attacks (TIA).] |
| Dementia | Dementia: Includes patients with chronic cognitive deficit. 0: No 1: Yes [Dementia or chronic cognitive deficit.] |
| Chronic pulmonary disease | Chronic pulmonary disease: Includes mild, moderat and severe pulmonary disease. For example: asthma, emphysema, chronic bronchitis 0: No 1: Yes [The patient has a mild or moderat or severe pulmonary disease.] |
| Peptic ulcer disease | Peptic ulcer disease: Any history of treatment for ulcer disease or history of ulcer bleeding. 0: No 1: Yes [Any history of treatment for ulcer disease or history of ulcer bleeding] |
| Liver disease | Liver disease: 0: None 1: Mild [Cirrhosis without portal hypertension or chronic hepatitis.] 3: Moderate to severe [Moderate: cirrhosis with portal hypertension, but without bleeding. Severe: cirrhosis with portal hypertension and a history of variceal bleeding.] |
| Connective tissue disease | Connective tissue disease: 0: No 1: Yes |
| Diabetes mellitus | Diabetes mellitus: 0: None or diet-controlled 1: Uncomplicated [Diabetes treated with insulin or oral hypoglycemics, but not diet alone.] 2: End-organ damage [Diabetes with end organ damage.] |
| Hemiplegia | Hemiplegia: 0: No 2: Yes |
| Moderate or severe renal disease | Moderate or severe renal disease: Moderate = creatinine >3 mg/dL (0.27 mmol/L).
Severe = on dialysis, status post kidney transplant, uremia. 0: No 2: Yes [Moderate: creatinine >3 mg/dL (0.27 mmol/L). Severe: on dialysis, status post kidney transplant, uremia.] |
| Solid tumor | Solid tumor: 0: None 2: Localized [Solid tumors without documented metastases.] 6: Metastatic [Metastatic solid tumor.] |
| Leukemia | Leukemia: 0: No 2: Yes |
| Lymphoma | Lymphoma: 0: No 2: Yes |
| AIDS | AIDS: Acquired immune deficiency syndrome. 0: No 6: Yes |
| CCI total score | CCI total score: The total sum of each component variable for the Charlson Comorbidity Index. |
| Estimated 10-year survival | Estimated 10-year survival: The predicted 10-year survival. Property: Qualified real Units: % |
| Other contributors | |
| Translators |